did not reach statistical significancep = 0.6254
Acetazolamide use was consistently higher in the RYGB group across all time points, though the differences did not reach statistical significance (24 months: 22.96% vs. 20.92%, RR: 1.098, 95% CI: 0.755–1.595, p = 0.6254).